These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 26140983)
1. GRID and docking analyses reveal a molecular basis for flavonoid inhibition of Src family kinase activity. Wright B; Watson KA; McGuffin LJ; Lovegrove JA; Gibbins JM J Nutr Biochem; 2015 Nov; 26(11):1156-65. PubMed ID: 26140983 [TBL] [Abstract][Full Text] [Related]
2. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Wright B; Moraes LA; Kemp CF; Mullen W; Crozier A; Lovegrove JA; Gibbins JM Br J Pharmacol; 2010 Mar; 159(6):1312-25. PubMed ID: 20148891 [TBL] [Abstract][Full Text] [Related]
3. Conformational insights into the inhibitory mechanism of phyto-compounds against Src kinase family members implicated in psoriasis. Sundarrajan S; Nandakumar MP; Prabhu D; Jeyaraman J; Arumugam M J Biomol Struct Dyn; 2020 Mar; 38(5):1398-1414. PubMed ID: 30963942 [TBL] [Abstract][Full Text] [Related]
4. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening. Lin LG; Xie H; Li HL; Tong LJ; Tang CP; Ke CQ; Liu QF; Lin LP; Geng MY; Jiang H; Zhao WM; Ding J; Ye Y J Med Chem; 2008 Aug; 51(15):4419-29. PubMed ID: 18610999 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors. Dincer S; Cetin KT; Onay-Besikci A; Ölgen S J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1080-7. PubMed ID: 22957720 [TBL] [Abstract][Full Text] [Related]
6. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex. Khuntawee W; Rungrotmongkol T; Hannongbua S J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011 [TBL] [Abstract][Full Text] [Related]
7. Essential moieties of myricetins, quercetins and catechins for binding and inhibitory activity against α-Glucosidase. Fu M; Shen W; Gao W; Namujia L; Yang X; Cao J; Sun L Bioorg Chem; 2021 Oct; 115():105235. PubMed ID: 34388484 [TBL] [Abstract][Full Text] [Related]
8. Structural study of ponatinib in inhibiting SRC kinase. Guo M; Duan Y; Dai S; Li J; Chen X; Qu L; Chen Z; Wei H; Jiang L; Chen Y Biochem Biophys Res Commun; 2022 Apr; 598():15-19. PubMed ID: 35151199 [TBL] [Abstract][Full Text] [Related]
12. Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors. Francini CM; Fallacara AL; Artusi R; Mennuni L; Calgani A; Angelucci A; Schenone S; Botta M ChemMedChem; 2015 Dec; 10(12):2027-41. PubMed ID: 26514807 [TBL] [Abstract][Full Text] [Related]
13. Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative. Chakraborty MP; Bhattacharyya S; Roy S; Bhattacharya I; Das R; Mukherjee A J Biol Chem; 2021; 296():100449. PubMed ID: 33617879 [TBL] [Abstract][Full Text] [Related]
14. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Agullo G; Gamet-Payrastre L; Manenti S; Viala C; Rémésy C; Chap H; Payrastre B Biochem Pharmacol; 1997 Jun; 53(11):1649-57. PubMed ID: 9264317 [TBL] [Abstract][Full Text] [Related]
15. Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles. Georghiou G; Kleiner RE; Pulkoski-Gross M; Liu DR; Seeliger MA Nat Chem Biol; 2012 Feb; 8(4):366-74. PubMed ID: 22344177 [TBL] [Abstract][Full Text] [Related]
16. Comparative study of the binding of 3 flavonoids to the fat mass and obesity-associated protein by spectroscopy and molecular modeling. Zhang L; Ren T; Wang Z; Wang R; Chang J J Mol Recognit; 2017 Jun; 30(6):. PubMed ID: 28058739 [TBL] [Abstract][Full Text] [Related]
17. A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region. Moroco JA; Baumgartner MP; Rust HL; Choi HG; Hur W; Gray NS; Camacho CJ; Smithgall TE Chem Biol Drug Des; 2015 Aug; 86(2):144-55. PubMed ID: 25376742 [TBL] [Abstract][Full Text] [Related]
18. Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src. Hari SB; Perera BG; Ranjitkar P; Seeliger MA; Maly DJ ACS Chem Biol; 2013 Dec; 8(12):2734-43. PubMed ID: 24106839 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis. Gu C; Stashko MA; Puhl-Rubio AC; Chakraborty M; Chakraborty A; Frye SV; Pearce KH; Wang X; Shears SB; Wang H J Med Chem; 2019 Feb; 62(3):1443-1454. PubMed ID: 30624931 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, Biological, and Computational Evaluation of Novel 1,3,5-Substituted Indolin-2-one Derivatives as Inhibitors of Src Tyrosine Kinase. Kilic-Kurt Z; Bakar F; Ölgen S Arch Pharm (Weinheim); 2015 Oct; 348(10):715-29. PubMed ID: 26260414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]